is part of the Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

  • American Agriculturist
  • Beef Producer
  • Corn and Soybean Digest
  • Dakota Farmer
  • Delta Farm Press
  • Farm Futures
  • Farm Industry news
  • Indiana Prairie Farmer
  • Kansas Farmer
  • Michigan Farmer
  • Missouri Ruralist
  • Nebraska Farmer
  • Ohio Farmer
  • Prairie Farmer
  • Southeast Farm Press
  • Southwest Farm Press
  • The Farmer
  • Wallaces Farmer
  • Western Farm Press
  • Western Farmer Stockman
  • Wisconsin Agriculturist

Representative Urges FDA to Reject Animal Drug

Chair of the House Rules Committee sends a letter to the FDA, warning of an animal drug that might cause human resistance to similar drugs.

The Food and Drug Administration should follow it's scientific advisory committee's recommendation and reject the animal drug cefquinome, U.S. Rep. Louise Slaughter, D-N.Y., said in a letter to the FDA.

Slaughter, the Chair of the House Rules Committee, says the use of the drug, used to treat life-threatening infections in animals, could cause resistance to similar drugs in humans.

"Given the recent outbreaks of E. coli and other food borne illnesses across the nation, it is hardly the time to ignore the advice of scientists, and potentially impair our ability to treat deadly infections," Slaughter says.

The FDA's Veterinary and Medical Advisory Committee recommended on September 25 against FDA approval of cefquinome in cattle over concerns that it could make similar drugs less effective in humans.

The drug's manufacturer, Intervet, has suggested it intends to continue to seek approval for the drug and has not withdrawn its applications to the FDA.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.